Abstract:Neurofibromatosis type 1 (NF1) is characterized predominantly by cafe-au-lait spots and fibromatous tumors of the skin [ [1] Crowe F.W. Schull W.J. Neel J.V. A clinical, pathological and genetic study of multiple neurofibromatosis. Charles C. Thomas, Springfield, IL1956 Google Scholar ] and is one of the most common autosome dominance hereditary disorders and is highly prevalent. Its incidence is 1/2000–1/5000 in Caucasians of western countries [ [2] Rasmussen S.A. Friedman J.M. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000; 151: 33-40 Crossref PubMed Scopus (312) Google Scholar ]. Its notable feature is that 40–50% of NF1 patients have no previous family history of the disease, indicating the new mutation rate is 1/10,000 [ 1 Crowe F.W. Schull W.J. Neel J.V. A clinical, pathological and genetic study of multiple neurofibromatosis. Charles C. Thomas, Springfield, IL1956 Google Scholar , 3 Huson S.M. Compston D.A. Clark P. Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989; 26: 704-711 Crossref PubMed Scopus (445) Google Scholar ]. The NF1 gene in chromosome 17 has been verified as the pathogenic gene of neurofibromatosis type 1 and many mutations were determined by a number of studies [ 4 Ars E. Serra E. Garcia J. Kruyer H. Gaona A. Lazaro C. et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet. 2000; 9: 237-247 Crossref PubMed Scopus (286) Google Scholar , 5 Fahsold R. Hoffmeyer S. Mischung C. Gille C. Ehlers C. Kucukceylan N. et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000; 66: 790-818 Abstract Full Text Full Text PDF PubMed Scopus (251) Google Scholar ]. Similar to de novo germline mutations in the retinoblastoma gene, the large majority of new NF1 mutations occur on paternally derived chromosomes [ [6] Jadayel D. Fain P. Upadhyaya M. Ponder M.A. Huson S.M. Carey J. et al. Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature. 1990; 343: 558-559 Crossref PubMed Scopus (157) Google Scholar ]. Up until now, the high mutation rate and the bias towards a paternal origin of NF1 mutations have not been adequately explained. Though numerous studies have reported gene mutations related to NF1 in patients of various races and ethnicity [ 4 Ars E. Serra E. Garcia J. Kruyer H. Gaona A. Lazaro C. et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet. 2000; 9: 237-247 Crossref PubMed Scopus (286) Google Scholar , 5 Fahsold R. Hoffmeyer S. Mischung C. Gille C. Ehlers C. Kucukceylan N. et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000; 66: 790-818 Abstract Full Text Full Text PDF PubMed Scopus (251) Google Scholar ], very few studies could be found concerning Chinese patients [ [7] Qiu W.Q. Shen Z.Z. Familial investigation and detection with DNA probe for neurofibromatosis in 4 generations. Hereditas (Beijing). 1992; 14 (in Chinese): 17-18 Google Scholar ].

Origins of Biallelic Inactivation of NF2 in Neurofibromatosis Type 2

A Novel NF2 Mutation Associated with Neurofibromatosis Type 2 Causes Aberrant Splicing and Phase Separation

Genetic Analysis and Prenatal Diagnosis of a Sporadic Family with Neurofibromatosis Type 1

Mutation Analysis of NF2 Gene and Clinical Investigation in a Chinese Family with Neurofibromatosis Type II

Analysis of families with hereditary neurofibromatosis type 2 gene mutation and clinical features

Individualized Diagnosis and Treatment of Neurofibromatosis Type Ⅱ Guided by Molecular Genetic Analysis

Epco-22. Deep Phenotyping Identifies Truncating Mutations In The Nf2 Linker Domain Associated With Disease Severity In Neurofibromatosis Type Ii

Proteomic and Genetic Analysis Reveals Loss of EPB41L3 Related to the Tumorigenesis of Neurofibromatosis Type 1 and Type 2

The Association of NF2 (neurofibromin 2) Gene Polymorphism and the Risk of Medulloblastomas.

Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status.

A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway

Characterization of Two Loss-of-Function NF1 Variants in Chinese Patients and Potential Molecular Interpretations of Phenotypes.

Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2

[Molecular Analysis of Two Pediatric Cases with Sporadic Neurofibromatosis Type 1].

Clinical diagnosis of neurofibromatosis type I in multiple family members due to cosegregation of a unique balanced translocation with disruption of the NF1 locus: Testing considerations for accurate diagnosis

The Investigation for Potential Modifier Genes in Patients with Neurofibromatosis Type 1 Based on Next-Generation Sequencing

Incidence of mosaicism in 1055 de novo NF2 cases: much higher than previous estimates with high utility of next-generation sequencing

Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity

Two novel mutations of the NF1 gene in Chinese Han families with type 1 neurofibromatosis

Current progress in genomics and targeted therapies for neurofibromatosis type 2

The genetic landscape and possible therapeutics of neurofibromatosis type 2